UBS assumed coverage of Emerson (EMR) with a Neutral rating and price target of $135, up from $120. The firm expanded its coverage of electrical equipment and multi-industry companies to include 16 large cap stocks. UBS believes we are overdue for recovery as the ISM Manufacturing PMI has been in contraction territory for 24 consecutive months, “by far the longest stretch of contraction in the last three decades.” There is also a clear inverse relationship between industrial output and interest rates, implying potential for a positive catalyst as interest rates further normalize, the analyst tells investors in a research note. The firm adds the outcome of the recent U.S. election gives way to potential for more robust short cycle recovery.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EMR:
- Emerson initiated with an Outperform at Exane BNP Paribas
- Emerson put volume heavy and directionally bearish
- Emerson price target raised to $140 from $136 at Deutsche Bank
- Emerson price target raised to $140 from $125 at KeyBanc
- Emerson price target raised to $125 from $118 at Baird
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
